The diagnostic process should begin with a pelvic ultrasound, followed by tumor marker assessment, including alpha-fetoprotein (AFP), beta-human chorionic gonadotropin (hCG), lactate dehydrogenase (LDH), and, if indicated, serum cancer antigen 125 (CA125). The gene discussed is MUC16; the disease is neoplasm.